Andrew Fire, Craig Mello, Mark Rogers, and Larry Gold

Apr 30, 2004

Premium

Andrew Fire, a professor of pathology and genetics at Stanford University School of Medicine, has been elected to the US National Academy of Sciences.

Fire, along with Craig Mello of the University of Massachusetts, discovered in 1998 that the RNAi mechanism could be triggered by introducing to a cell long double-stranded RNAs.

Aptamera, a drug development company focusing on aptamer therapeutics, said this week that it has appointed Mark Rogers as its chairman.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Links Between Them

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

Retaliation Claim

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

Good Samples Under the Glass

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

This Week in PNAS

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.

Featured White Papers

iPSC & CRISPR/Cas9 Technologies Enable Precise & Controlled Physiologically Relevant Disease Modeling for Basic & Applied Research

Tissue Section Imaging

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Nov

15

Featured Webinar

Next-Generation Platforms for Strain Optimization: Reducing the Cost and Time for Commercializing Novel Biological Molecules

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Dec

03

Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec

04

Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Main menu